Check pralmorelin identity and documentation
GHRP-2 should be evaluated independently from GHRP-6 or ipamorelin. A shared secretagogue category cannot establish an equivalent formulation or evidence base.
Documentation to request
Ask the reviewer to reconcile the GHRP-2/pralmorelin naming, salt and analytical specification with the exact quoted item.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Hormone clinic purchasing review. These references support a review, not a treatment recommendation or supply authorization.